TICKERNERD
Menu
SBCSBCIndustrials · Consulting Services

SBC Stock Forecast: SBC Medical Group Holdings, Inc. Price Predictions for 2026-2027

Last close, 21 Aug 2026
$4.00
+8.70% on the day

The 3 Wall Street analysts covering SBC Medical Group Holdings, Inc. hold a median 12-month price target of $8.5 — +112.5% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 71 of 100 as at 22 Aug 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$411.4M
Ticker Nerd rank
71 / 100
Median analyst target
$8.50
Analysts covering
3
Total return, dividends reinvested
1W
+9.3%
1M
+34.2%
YTD
−7.2%
1Y
−5.4%
From 52W high
−19.8%
From 52W low
+39.4%
$2.87
$4.99
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

SBC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores SBC Medical Group Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 22 Aug 2026
71 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Value
99
Volatility
90
Quality
88
Revisions
70
Size
56
Accruals
54
Momentum
35
Growth
34
Issuance
23

Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.

Issuance (23): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

SBC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on SBC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$2.00$4.00$6.00$8.00$10.00Oct 25Jan 26Apr 26Jul 26SBCHigh $10.00Median $8.50Low $7.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says3 analysts
3 Buy0 Hold0 Sell
Low $7.00Median $8.50High $10.00

The green dot is the last close — the median target sits +112.5% from it.

Recent analyst actionsNewest first
DateFirmActionRatingTarget
13 Aug 2026BTIGReiteratesBuy$8.00
6 Mar 2026BTIGInitiatesBuy—
6 Mar 2026BTIGInitiatesBuy$8.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. SBC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

SBC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.6%
Analysts raising
2
Analysts cutting
1
Fundamentals

SBC Medical Group Holdings, Inc. (SBC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
8.3×

Cheaper than 62% of US stocks

Price / sales
2.3×

Cheaper than 50% of US stocks

Price / book
1.6×

Cheaper than 57% of US stocks

EV / EBITDA
4.2×

Cheaper than 55% of US stocks

Growth & margins
Revenue growth (YoY)
13.4%

Higher than 60% of US stocks

Earnings growth (YoY)
335.0%

Higher than 93% of US stocks

Gross margin
70.5%

Higher than 83% of US stocks

Operating margin
38.5%

Higher than 91% of US stocks

Net margin
28.0%

Higher than 87% of US stocks

Returns & dividend
Return on equity
18.9%

Higher than 80% of US stocks

Return on assets
11.3%

Higher than 94% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

SBC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelConsulting Services
CompanyMarket capTKN rank
SBCSBC Medical Group Holdings, Inc.$411.4M
71
PPHCPublic Policy Holding Co., Inc.$319.1M
33
ROMARoma Green Finance Ltd.$535.5M
20
FORRForrester Research, Inc.$223.9M
79
CRAICRA International, Inc.$1.2B
47
RGPResources Connection, Inc.$144.9M
52
ICFIICF International, Inc.$1.6B
79

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own SBC Medical Group Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest SBC news & analysis

SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%

MarketBeat · 19 Aug 2026positive

SBC Medical Group reported that its growth re-accelerated in the second quarter of 2026, with EBITDA surging 32%. The company attributed the performance to completed structural reforms from 2025, an expanded clinic network, and increased management-services revenue.

Why it matters — The re-accelerated growth and 32% EBITDA increase indicate that SBC's 2025 structural reforms and network expansion are translating into stronger financial results.

SBC Medical Group Holdings Incorporated (SBC) Q2 2026 Earnings Call Transcript

Seeking Alpha · 13 Aug 2026neutral

A Seeking Alpha report presents the transcript of SBC Medical Group Holdings, Incorporated's Q2 2026 earnings call. The item relays the company's quarterly earnings discussion as covered by the source publication.

Why it matters — SBC watchers would find the transcript useful for following management's latest quarterly commentary on company performance.

SBC Medical Group Q2 Earnings Call Highlights

MarketBeat · 13 Aug 2026positive

SBC Medical Group reported second-quarter 2026 results showing a reacceleration in growth following structural reforms undertaken in 2025. Adjusted EBITDA grew faster than revenue, despite a weaker yen weighing on reported figures.

Why it matters — The faster adjusted EBITDA growth relative to revenue signals improving efficiency following the company's 2025 restructuring, giving SBC watchers a gauge of post-reform momentum.

SBC Medical Group Holdings Reports Second Quarter 2026 Financial Results

Business Wire · 13 Aug 2026positive

SBC Medical Group Holdings reported second quarter 2026 financial results, with revenue up 13%, net income up 335%, and adjusted EBITDA up 32% year-over-year. The company stated its restructuring is complete and growth is reaccelerating.

Why it matters — A SBC watcher would care because the report shows strong year-over-year gains across revenue, net income, and adjusted EBITDA following completion of its restructuring.

SBC Medical to Announce 2Q 2026 Financial Results

GlobeNewsWire · 3 Aug 2026neutral

SBC Medical Group Holdings announced that it will release its second quarter 2026 financial results, for the period ended June 30, 2026, before the U.S. market opens on August 13, 2026. The company provides management support across a wide range of healthcare fields.

Why it matters — The announcement gives SBC watchers a confirmed date to expect its latest quarterly financial performance, which is a key near-term reporting event for the company.

FAQ

Frequently asked questions about SBC stock

What is the SBC stock price forecast for 2026-2027?

The 3 Wall Street analysts covering SBC Medical Group Holdings, Inc. have a median 12-month price target of $8.5, with estimates ranging from $7 to $10. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is SBC stock a buy right now?

Of the 3 analysts covering SBC Medical Group Holdings, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SBC Medical Group Holdings, Inc. 71 out of 100 across roughly 4,600 US stocks as at 22 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank SBC?

As at 22 Aug 2026, SBC Medical Group Holdings, Inc. ranks 71 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).

Will SBC stock go up?

No one can know that. What the data says: the median 12-month target from 3 analysts implies +112.5% from the last close, and Ticker Nerd's factor model ranks SBC Medical Group Holdings, Inc. 71 out of 100 as at 22 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the SBC stock forecast for 2030?

No analyst covering SBC Medical Group Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SBC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $7 to $10 over the next 12 months.

How has SBC stock performed over the past year?

SBC Medical Group Holdings, Inc. returned -5.4% over the 12 months to 21 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does SBC Medical Group Holdings, Inc. do?

SBC Medical Group Holdings Inc. is a dedicated entity within the healthcare sector, primarily focused on managing and developing medical facilities and services.

What is the latest news on SBC?

The most recent item we track (MarketBeat, 19 Aug 2026): "SBC Medical Group Q2 Growth Re-Accelerates as EBITDA Surges 32%". SBC Medical Group reported that its growth re-accelerated in the second quarter of 2026, with EBITDA surging 32%. The company attributed the performance to completed structural reforms from 2025, an expanded clinic network, and increased management-services revenue.

Company

About SBC Medical Group Holdings, Inc.

SBC Medical Group Holdings Inc. is a dedicated entity within the healthcare sector, primarily focused on managing and developing medical facilities and services. The company specializes in providing comprehensive healthcare solutions that include the management of hospitals, outpatient centers, and specialized clinics. SBC Medical Group plays a pivotal role in enhancing healthcare access and quality by integrating advanced medical technologies and innovative patient care models. This entity serves various demographics, including urban and rural communities, ensuring that a broad spectrum of patients have access to necessary healthcare services. With a commitment to medical excellence and patient-centric care, SBC Medical Group supports healthcare professionals by offering state-of-the-art infrastructure and resources needed for efficient healthcare delivery. In the financial market, SBC operates as a significant contributor to the healthcare industry's growth narrative, attracting investors looking to participate in a stable and essential sector with long-term growth potential.

CEO Dr. Yoshiyuki Aikawa · 863 employees · United States · https://sbc-holdings.com